Africa (WHO region) vs Antigua and Barbuda: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy)

Africa (WHO region)
89.0%
in 2014
Antigua and Barbuda
100.0%
in 2014
Africa (WHO region) rank
2nd
Antigua and Barbuda rank
1st

HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) over time

  • Africa (WHO region)
  • Antigua and Barbuda
020406080100200320082014

How they compare

Antigua and Barbuda currently reports 100.0% against 89.0% in Africa (WHO region), a difference of 11.0%.

That makes Antigua and Barbuda's figure about 1.1 times Africa (WHO region)'s.

The two have swapped places 2 times across 8 shared years of data; in 2004 it was Antigua and Barbuda ahead.

Africa (WHO region) ranks 2nd and Antigua and Barbuda ranks 1st of 11 groups.

Across the 2 decades both report, Africa (WHO region) averaged higher in 1 and Antigua and Barbuda in 1.

Head to head by decade

Decade Africa (WHO region) Antigua and Barbuda Difference Ahead
2000s 88.0% 100.0% 12.0% Antigua and Barbuda
2010s 85.0% 78.0% 7.0% Africa (WHO region)

Averages of every year both report within each decade.

Frequently asked questions

Which has higher hiv-positive tb patients on cpt (co-trimoxazole preventive therapy), Africa (WHO region) or Antigua and Barbuda?
Antigua and Barbuda, at 100.0% against 89.0% in Africa (WHO region) as of 2014.
What is the difference in hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) between Africa (WHO region) and Antigua and Barbuda?
11.0%, with Antigua and Barbuda ahead.
How many years of comparable data are there for Africa (WHO region) and Antigua and Barbuda?
8 years are reported by both, from 2004 to 2014.
How do Africa (WHO region) and Antigua and Barbuda rank globally for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
Africa (WHO region) ranks 2nd and Antigua and Barbuda ranks 1st of 11 groups.
Where does this data come from?
World Health Organization, Global Health Observatory, published as HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Africa (WHO region) vs Antigua and Barbuda: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 18 September 2026, from https://health.statizoid.com/compare/hiv-positive-tb-patients-on-cpt-co-trimoxazole-preventive-therapy-percent/africa-who-region/antigua-and-barbuda/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/hiv-positive-tb-patients-on-cpt-co-trimoxazole-preventive-therapy-percent/africa-who-region/antigua-and-barbuda/">Africa (WHO region) vs Antigua and Barbuda: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy)</a> — Statizoid

About this data

Indicator
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
117 places, 985 data points, 2003–2014
Last refreshed